https://www.sciencedaily.com/releases/2019/12/191217114232.htm
https://multiple-sclerosis-research.org/2019/12/adamas-announces-top-line-results-from-inroads-phase-3-trial-of-ads-5102-for-multiple-sclerosis-patients-with-walking-impairment/
https://multiple-sclerosis-research.org/2019/12/antibody-levels-drop-after-alemtuzumab-as-infections-occur-lessons-for-ocreliziumab-use/
https://multiple-sclerosis-research.org/2019/12/hsct-in-norge/
https://multiple-sclerosis-research.org/2019/12/apathy-does-it-affect-you/
https://multiple-sclerosis-research.org/2019/12/t-cells-and-cortical-lesions-is-siponimod-the-next-thing-to-sort-out-cog-fog/
https://www.msif.org/news/2019/12/13/remyelination-therapies-on-trial/
